- Multi-year agreement to launch in early 2023
- Bioformis was selected due to its industry-leading technical capabilities as well as the breadth of operational, clinical and technology services for its end-to-end solutions
boston And Orlando, Fla., January 23, 2023 /PRNewswire/ — Biofourmis, a leading global technology-enabled care delivery provider, today announced a multi-year agreement with Orlando Health, a non-profit healthcare organization serving the Southeast regions Is. United States of america, Orlando Health will leverage Bioformis’ solution to support its program, which will enable providers Central Florida To provide hospital level care to patients in their homes safely and effectively.
Orlando Health is a 3,238-bed system consisting of 23 hospitals and emergency departments – 18 of which are currently operational and five are coming soon. More than 4,000 physicians representing more than 100 medical specialties and subspecialties are privileged to the Orlando Health System, which employs more than 25,000 team members and more than 1,200 physicians. In its fiscal year 2022, Orlando Health will serve more than 142,000 inpatients and 3.9 million outpatients.
“We are working closely with Orlando Health to develop a program that we expect will become one of the largest and most successful hospital-at-home programs in the U.S. Will expand access to quality hospital-level care. Central FloridaKuldeep Singh Rajput, CEO and Founder of Bioformis, said, “Our solution is built to scale rapidly and scale to Orlando Health’s needs, including our end-to-end technology platform that delivers a comprehensive, continuously updated patient provides visual and actionable care insights, as well as round-the-clock support from our technical, operational and clinical teams. In no time, we expect Hospital-at-Home to become a popular care destination for patients across the region service, ensuring adequate access to critically ill and injured patients who require facility-based care.”
ready to grow
Orlando Health’s hospital-at-home program is expected to begin in early 2023. Patient numbers are expected to continue to rise as health systems gain experience with new care delivery approaches.
Bioformis’ solution continuously collects vital signs and physiologic signs, and its FDA-cleared BioVitals™ The analytics engine creates a personalized baseline for each patient that can help physicians provide appropriate care. Orlando Health providers can review all data and insights on a continuously updated physician dashboard and, at a glance, providers can evaluate each patient trajectory. Patients will also have access to their providers through home visits as well as virtual visits and other communications through the patient app.
Orlando Health selected Bioformis after a rigorous proposal evaluation process that included four other potential vendors. In addition to the Biofourmis solution’s advanced remote patient monitoring and management and data science capabilities, Orlando Health chose Biofourmis because of the broad range of end-to-end services offered with the platform, including in-home assisted service ordering and coordination Includes provider scheduling. , patient support, and seamless interoperability with the health system’s EPIC electronic health record system.
“Delivering hospital-level care within the patient’s home has been a goal for Orlando Health. This comprehensive solution ensures the safest, highest-quality care as well as ease of use for patients and providers.” Jamal Hakeem, MD, Orlando Health chief operating officer. “We are confident that our organization’s dedicated focus on patients, clinical excellence and operational efficiency – supported by Bioformis’ solutions – will drive the growth of a successful hospital-at-home program.”
Bioformis brings the right care to every individual, wherever they are. The company’s AI-powered solution collects and analyzes over 120 biomarkers in real time and identifies changes that require proactive intervention. This groundbreaking innovation gives people everywhere access to hospital-level services, virtual provider networks for remote care, and life-changing clinical trials—all without leaving their homes. Trusted by leading health systems, payers, biopharma companies and patients alike, Bioformis’ connected platform improves patient outcomes, prevents hospital readmissions, accelerates drug development, and improves care Closes critical gaps – ultimately making science smarter, healthcare simpler and patients healthier. Biofourmis a global technology company enabling care delivery, is headquartered in boston and head offices Singapore And India, For more information, visit biofourmis.com and follow Biofourmis on LinkedIn, Twitter and youtube.
About Orlando Health
Orlando Health Headquarters Orlando Floridais a non-profit health care organization $8.1 billion of assets under management that serves the Southeast United States of america,
Established more than 100 years ago, the healthcare system is recognized worldwide Central Florida The only state-accredited Level II adult trauma center with the only pediatric and adult Level I trauma program Pinellas County, It is home to the nation’s largest neonatal intensive care unit under one roof, the only system in the southeast to offer open fetal surgery to repair the most severe forms of spina bifida, site of an Olympic athlete training facility and operator of one of the largest and highest performing clinically integrated networks in the region. Orlando Health pioneers life-changing medical research and its graduate medical education program hosts more than 350 residents and fellows.
The system includes nine specialty institutions, more than 100 adult and pediatric primary care practices, skilled nursing facilities, an inpatient behavioral health facility under the management of Acadia Healthcare, and more than 60 outpatient facilities including imaging and laboratory services, wound Are included. Care Center in partnership with LHC Group, Home Healthcare Services and Urgent Care Center in partnership with Fastmed Urgent Care.
provided more than the healthcare system $782 million This is in aggregate value for communities serving charity care, community benefit programs and services, community building activities and more in FY21, the most recent period for which this information is available. Additional information can be found at http://www.orlandohealth.com, or follow us on LinkedIn, Facebook, Instagram and Twitter @orlandohealth.
Amendola Communications for Bioformis